The Role for Radical Prostatectomy in Advanced Prostate Cancer
作者： R. Jeffrey Karnes , Michael L. Blute
DOI: 10.1007/978-1-60761-259-9_17
关键词:
摘要: Radical prostatectomy can be an effective treatment in the management of high-risk or locally advanced prostate cancer. provides accurate pathologic grading and staging when used alone as part multimodal result acceptable long-term local control cancer survival.
springer.com
elsevier.com
sci-hub.st 参考文章(53)
James Mohler, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony D'Amico, James A. Eastham, Charles A. Enke, Daniel George, Eric Mark Horwitz, Robert P. Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H. Lange, Gary MacVicar, Elizabeth R. Plimack, Julio M. Pow-Sang, Mack Roach, Eric Rohren, Bruce J. Roth, Dennis C. Shrieve, Matthew R. Smith, Sandy Srinivas, Przemyslaw Twardowski, Patrick C. Walsh, Prostate cancer. Clinical practice guidelines in oncology. Journal of The National Comprehensive Cancer Network. ,vol. 8, pp. 162- 200 ,(2010) , 10.6004/JNCCN.2010.0012
Masahiro Aihara, Russell M. Lebovitz, Thomas M. Wheeler, Beatriz M. Kinner, Makoto Ohori, Peter T. Scardino, Prostate Specific Antigen and Gleason Grade: An Immunohistochemical Study of Prostate Cancer The Journal of Urology. ,vol. 151, pp. 1558- 1564 ,(1994) , 10.1016/S0022-5347(17)35302-8
Patterns of prostate cancer treatment by clinical stage and age. American Journal of Public Health. ,vol. 91, pp. 126- 128 ,(2001) , 10.2105/AJPH.91.1.126
M. Manoharan, V.G. Bird, S.S. Kim, F. Civantos, M.S. Soloway, Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8 BJUI. ,vol. 92, pp. 539- 544 ,(2003) , 10.1046/J.1464-410X.2003.04419.X
Matthew K. Tollefson, Michael L. Blute, Laureano J. Rangel, Erik J. Bergstralh, Stephen A. Boorjian, R. Jeffrey Karnes, The effect of Gleason score on the predictive value of prostate-specific antigen doubling time. BJUI. ,vol. 105, pp. 1381- 1385 ,(2009) , 10.1111/J.1464-410X.2009.08976.X
HORST ZINCKE, WEBER LAU, ERIK BERGSTRALH, MICHAEL L. BLUTE, Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. The Journal of Urology. ,vol. 166, pp. 2208- 2215 ,(2001) , 10.1016/S0022-5347(05)65536-X
Horst Zincke, Erik J. Bergstralh, Jeffrey J. Larson-Keller, George M. Farrow, Robert P. Myers, Michael M. Lieber, David M. Barrett, Charles C. Rife, Nick J. Gonchoroff, Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Cancer. ,vol. 70, pp. 311- 323 ,(1992) , 10.1002/1097-0142(19920701)70:1+<311::AID-CNCR2820701320>3.0.CO;2-T
Brett S. Carver, Fernando J. Bianco, Peter T. Scardino, James A. Eastham, Long-Term Outcome Following Radical Prostatectomy in Men With Clinical Stage T3 Prostate Cancer The Journal of Urology. ,vol. 176, pp. 564- 568 ,(2006) , 10.1016/J.JURO.2006.03.093
Koichiro Akakura, Shigeo Isaka, Susumu Akimoto, Haruo Ito, Kiyoki Okada, Takahiko Hachiya, Osamu Yoshida, Yoichi Arai, Michiyuki Usami, Toshihiko Kotake, Ken-Ichi Tobisu, Yasuo Ohashi, Yoshiteru Sumiyoshi, Tadao Kakizoe, Jun Shimazaki, Long-term results of a randomized trial for the treatment of stages B2 and C prostate cancer : Radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities Urology. ,vol. 54, pp. 313- 318 ,(1999) , 10.1016/S0090-4295(99)00106-5
Stephen A. Boorjian, R. Jeffrey Karnes, Laureano J. Rangel, Eric J. Bergstralh, Michael L. Blute, Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy Journal of Urology. ,vol. 179, pp. 1354- 1361 ,(2008) , 10.1016/J.JURO.2007.11.061